 rel resist primari isol neutral solubl replic human immunodefici viru type pathogenesi progress acquir immunodefici syndrom aid solubl form viru receptor potenti therapeut agent good activ laboratori strain vitro quantit virolog studi date blood patient recombin solubl efficaci vivo good drug level serum result neutral activ multipl primari isol infect patient find primari isol resist laboratori strain need therapi preclin studi experi patient viral isol